Skip to content

AvePoint, Inc. AVPT Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

AMB
Ambiq Micro, Inc.AMBQ
$3.01M
TRV
Trevi Therapeutics, Inc.TRVI
$2.54M
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
Rigetti Computing, Inc. logo
Rigetti Computing, Inc.RGTI
$30K-92.7%
KEE
Keel Infrastructure Corp. Common StockKEEL
$11.48M
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%

Other financials

Income statement

See full
Revenue$117.2M+26.0%
Gross profit$85.4M+23.4%
Operating income$12.7M+287%
Net income$15.3M+343%
EPS (diluted)$0.07+250%

Balance sheet

See full
Cash & equivalents$444.1M+26.4%
Total debt$22.0M+22.2%
Total equity$200.1M-14.0%
Total assets$734.2M+22.6%

Cash flow

See full
Operating cash flow$24.3M+4,801%
CapEx$1.3M-15.7%
Free cash flow$23.0M+2,355%

Valuation

See full
Market cap$2.19B-29.9%
Enterprise value$1.76B-37.1%
P/E46.7×
P/S4.9×-4.0×

Profitability

See full
Gross margin73.7%-1.7pp
Operating margin9.6%+5.7pp
Net margin10.5%+7.6pp
FCF margin23.8%+1.6pp

Returns & leverage

See full
Return on equity-17.9%+3.5pp
Debt / equity0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AvePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: AvePoint, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AvePoint, Inc.'s proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AvePoint, Inc.'s proceeds from warrant exercises?
AvePoint, Inc. (AVPT) reported proceeds from warrant exercises of $0 in Q1 2026.
How has AvePoint, Inc.'s proceeds from warrant exercises changed year-over-year?
AvePoint, Inc.'s proceeds from warrant exercises decreased by 100.0% year-over-year, from $87.34M to $0.
What does proceeds from warrant exercises mean?
Cash inflows received by the company when holders of warrants exercise their right to purchase common stock at a predetermined strike price. This represents a source of equity financing that increases the company's cash position while simultaneously increasing the number of shares outstanding. It is a key indicator of potential future dilution and capital infusion from derivative instruments.